Showing 1 - 10 of 14
The fairly recent discovery and growing use of costly, revolutionary biotechnology drugs (e.g., GM-CSFs) in hospitals represent a major technical innovation in clinical pharmacy intervention. This paper models the translog production cost impacts of ten distinct clinical pharmacy tasks including...
Persistent link: https://www.econbiz.de/10010988866
Persistent link: https://www.econbiz.de/10005015383
Health care expenditure studies of the Organization for Economic Cooperation and Development (OECD) countries remain important because their findings often suggest cost containment and other policy initiatives. This paper focuses on the compatibility of OECD health data with the “expenditure...
Persistent link: https://www.econbiz.de/10005680720
Persistent link: https://www.econbiz.de/10005716918
Classical regression estimates of the determinants of the OECD health expenditures are useful for policy formulation and evaluation. However, if the underlying timeseries data are not collectively stationary in levels, the estimated parameters are faulty and can misguide health policy. Until...
Persistent link: https://www.econbiz.de/10009210063
Persistent link: https://www.econbiz.de/10008926367
Persistent link: https://www.econbiz.de/10011541958
Persistent link: https://www.econbiz.de/10011898941
Persistent link: https://www.econbiz.de/10011565367
Persistent link: https://www.econbiz.de/10011647760